Article info
Original research
Ceftolozane–tazobactam in an elastomeric infusion device for ambulatory care: an in vitro stability study
- Correspondence to Dr Edward Raby, Infectious Diseases, Fiona Stanley Hospital, Murdoch WA 6150, Australia; edward.raby{at}health.wa.gov.au
Citation
Ceftolozane–tazobactam in an elastomeric infusion device for ambulatory care: an in vitro stability study
Publication history
- Received September 16, 2019
- Revised November 22, 2019
- Accepted December 4, 2019
- First published December 16, 2019.
Online issue publication
April 30, 2020
Article Versions
- Previous version (26 March 2020).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© European Association of Hospital Pharmacists 2020. No commercial re-use. See rights and permissions. Published by BMJ.